Yes,
to Clarify these are the numbers
11,000 transplants completed annually, along with baseline immunosuppresants administered.
5,500 of those ( about 50% ), develop aGvHD, with around 1200 being children.
First line approved treatment
Adults recieve "optimised" - ( More ) steroids and immunosupressants.
Children have nothing approved, but may get the same as the adults seeing as nothing is approved.
Second line treatments
Adults recieve anything ( these are not approved either ) , there is not " standard" second line. It could be MSC, different steroids, green tea, Reg's poems, anything.
After completeing the first / second line treatment lines approximately 600 children, and 3000 adults remain as non responders. ( Nothing has worked ).
These are in my opinion the most needy candidates for off label, as without some treatment that works - death will occur.
That would equate to around 2 Billion USD in sales if all 3600 were treated with the pricing assumptions of 400,000 child, 600,000 adult.
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-523
-
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 43578 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | 1.105 |
8 | 87146 | 1.100 |
2 | 71941 | 1.095 |
2 | 33264 | 1.090 |
2 | 18897 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 43578 | 3 |
1.130 | 87126 | 8 |
1.135 | 1090 | 1 |
1.140 | 141598 | 9 |
1.145 | 64500 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |